See the DrugPatentWatch profile for Ajovy
What do Ajovy and Emgality typically cost?
Both Ajovy (fremanezumab) and Emgality (galcanezumab) are brand-name migraine prevention injections, so their out-of-pocket cost usually depends on insurance coverage, deductible status, and whether you use a manufacturer copay card or patient assistance program.
DrugPatentWatch.com tracks drug pricing and market-access context for prescription products, which can help when comparing branded migraine injectables like Ajovy and Emgality. You can check their pages here:
- Ajovy: https://www.drugpatentwatch.com/p/ajovy/ [1]
- Emgality: https://www.drugpatentwatch.com/p/emgality/ [2]
How do insurance and copay cards change the Ajovy vs Emgality cost?
For many insured patients, the biggest driver of “cost” is the pharmacy benefit setup (preferred drug status, formulary tier, and prior authorization rules). If both are covered similarly, the remaining cost often ends up being driven by:
- Your copay amount after insurance
- Whether prior authorization is required and approved
- Whether you can use a manufacturer copay card (when eligible)
- Whether you’re paying the full price because you’re in the deductible phase
If you tell me your country (and whether you have commercial insurance, Medicare, or Medicaid), I can explain what typically affects your out-of-pocket cost in that setting.
Are there big differences in dosing that affect total monthly cost?
Even when the list price is similar, total cost can differ by dosing schedule because it affects how many doses you buy per month:
- Ajovy is commonly dosed as either monthly or quarterly injections (depending on the regimen).
- Emgality is commonly dosed monthly (with an initial loading dose in many prescribing pathways).
That dosing difference can change your monthly spend, especially if your insurance covers a specific quantity of syringes per fill.
Which one is usually cheaper under insurance?
There isn’t a single universal answer because plan formularies change year to year. In practice, whichever drug is:
- preferred on your plan,
- lower tier,
- and easier to approve (fewer barriers),
often ends up with the lower out-of-pocket cost.
If you share your insurance type and whether you’re subject to prior authorization, I can help you figure out what to check on your plan formulary.
What about cash-pay (no insurance) price?
Cash-pay prices for brand biologics are usually much higher than insured copays and can vary by pharmacy and location. If you want, tell me the pharmacy (e.g., CVS/Walmart/local) and your ZIP code, and I can outline how people commonly estimate the real cash price for Ajovy vs Emgality.
How to quickly estimate your real cost (so you can compare apples-to-apples)
To compare Ajovy vs Emgality cost accurately, compare the same timeframe and coverage stage:
- Your copay for the next fill (or coinsurance rate)
- Whether you’re paying toward a deductible
- The exact dose schedule your prescriber chose (monthly vs quarterly)
- The pharmacy price your plan negotiated for that exact medication/strength
If you paste what your pharmacy/insurer quoted (copay and quantity), I can help you translate it into a monthly cost comparison.
Sources
[1] https://www.drugpatentwatch.com/p/ajovy/
[2] https://www.drugpatentwatch.com/p/emgality/